Activate Now
 
ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Patient Insights into the Design of Technology to Support a Strengths-Based Approach to Health Care.

SURVEY: Weight Management & Chronic Illness

Japanese green tea consumers have reduced risk of dementia

Do Nothing, Accomplish Everything! The Connection Between Breathing and Healing

Meet the ProHealth Editors

Best Herbs to Help With Insomnia

Choline: Why You Should Eat Your Egg Yolks and Take Krill

Calcium, vitamin D supplementation associated improved stroke recovery

Acupressure reduced fatigue in breast cancer survivors

More positive evidence for melatonin in breast cancer battle

 
Print Page
Email Article

People with AIDS illnesses more prone to memory problems

  [ 146 votes ]   [ Discuss This Article ]
www.ProHealth.com • August 8, 2000


People whose diagnosis of AIDS was based on specific illnesses are at greater risk of developing memory problems than are people whose diagnosis grew from low immune-cell counts, new research shows.

The study found that AIDS patients who were diagnosed because of so-called AIDS-defining illnesses, such as Kaposi's sarcoma, are most at risk for memory loss and other cognitive problems, including dementia.

The findings are important because the life-preserving treatment regimens taken by people with AIDS are very complex, and a person with memory or cognitive problems may not be able to follow those regimens.

"It is important to identify those who are at risk for dementia and to help them to the extent that we can," said Robert Bornstein, professor and chair of psychiatry at Ohio State University and co-author of the study.

"Not following a treatment regimen can allow medication-resistant strains of the virus to evolve in that person because of the way the virus interacts with these drugs."

Furthermore, he said, "the same cognitive difficulties that influence a person's ability to follow their medication regimen can contribute to increased risky behavior, and an increased risk of HIV transmission. Then you end up with a person who is transmitting a drug-resistant strain of the virus, which raises a broader public health concern."

Doctors still cannot predict which patients are at risk of developing cognitive problems, however, because there is too much variation among individuals.

The study, conducted with Michael Basso of the University of Tulsa and published in a recent issue of the Journal of Clinical and Experimental Neuropsychology, followed 200 homosexual men over a six-month period.

Seventy-four of the men tested positive for HIV but showed no symptoms of disease, 31 were HIV positive and had early signs of disease, 23 had AIDS-defining illnesses, and 10 were diagnosed with AIDS because they had CD4 cell counts below 200/mm3 (CD4 cells are the immune cells that are destroyed in the course of HIV disease). These groups were compared to a control group of 62 matched men who were not infected with HIV.

AIDS-defining illnesses are those that were identified by the Centers for Disease Control and Prevention (CDC) as indicative of severe immune suppression and diagnostic of AIDS in their own right. They include such diseases as Kaposi's sarcoma, Pneumocystis pneumonia, and candidiasis of the lung and airway.

Study participants were given baseline tests for attention, dexterity, and verbal learning and recall. Participants were tested again six months later.
No differences were found in attention or dexterity after 6 months, but in learning and recall, the group with AIDS-defining illnesses did significantly more poorly than all other groups.
The researchers speculated that no differences were found in attention and dexterity because the six-month time interval between testing may have been too brief to reveal differences. Verbal learning and recall, however, are both important for complying with complex treatment regimens.

The men involved in the study were tested between 1991 and 1996, prior to the use of protease inhibitors, a class of drugs that are now commonly used in combination with other antiretroviral drugs to treat people with HIV disease and AIDS.

"The therapeutic options and medication regimens that are available today will almost certainly change the impact of this," said Bornstein. "But there are still lots of people who are infected with HIV and who remain untreated, and many are now living long after they are diagnosed with AIDS because of the new therapeutic options."

Bornstein suggests that physicians who are treating people with HIV should stay alert for signs of emerging cognitive deficit in their patients, particularly in patients with AIDS-defining illnesses. Bornstein, who has been studying people with HIV since 1989, is now working to identify specific factors that increase a person's risk of developing dementia and factors that may influence the course of decline.

This research was funded by grants from the National Institute of Mental Health, the National Institute on Alcohol Abuse and Alcoholism, and the National Institute on Drug Abuse.



Post a Comment

Featured Products From the ProHealth Store
Vitamin D3 Extreme™ FibroSleep™ Ultra ATP+, Double Strength

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
Natural Pain Relief Supplements

Featured Products

Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength

Natural Remedies

Clinically Studied Joint Relief Product for FM & ME/CFS Clinically Studied Joint Relief Product for FM & ME/CFS
How I Found My Long-Lost Energy How I Found My Long-Lost Energy
Improve Cardiovascular and Metabolic Health with Omega-7 Improve Cardiovascular and Metabolic Health with Omega-7
Prepare Yourself for Cold & Flu Season Prepare Yourself for Cold & Flu Season
Dreaming of a Good Night's Sleep? Dreaming of a Good Night's Sleep?

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE AND SAVE 15% NOW*
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map